Oral Polio Vaccine has been causally linked to Cancer & AIDS.
While the Polio Eradication Initiative (PEI) is under attack for its reported
failure in tackling polio, causing the same disease amongst 85,000 vaccinated
children as per the Indian Medical Association, causing the spread of a new
vaccine induced polio virus, and for allowing the highly unethical trials of an
untested monovalent polio vaccine mOPV1 without informing the parents of
children who have been vaccinated with it, we are surprised why the even more
serious issue of the vaccine capable of causing Cancer and AIDS is not being
discussed. It is amazing how the WHO, UNICEF, CDC and Rotary International are
keeping quiet and allowing the vaccine to run riot in India.
The Oral Polio Vaccine (OPV) is notorious for spreading the simian virus SV40,
an extremely carcinogenic substance, that has been causally linked to Non
Hodgkins Lymphoma, many types of brain tumours, bone cancers, cancer of the
lymph nodes and even blood cancer.
While it has been established beyond doubt that the green monkey serum used in
the OPV was contaminated by SV40 in the 1950s, legal attorneys in the USA have
declared in the year 2000 that the vaccine is not free of this dreaded simian
virus as revealed by internal memos of the manufacturers. Vaccine researchers
say that keeping the OPV free of contaminating viruses is an impossibility as
it is a live virus vaccine and efforts to kill any stranger virus would result
in weakening or killing the vaccine strain.
Once inside the human body the virus SV40 is capable of causing cancer after 40
to 50 years of taking the vaccine. That is, children vaccinated today would be
at risk of developing cancer upto the year 2057. Indian doctors are well aware
of this risk but are unable to declare the same to the public. This information
is also available with honourable members of the Indian Press and TV media.
The OPV is also contaminated with the Simian Immunodeficiency Virus SIV.
Genetic studies of the monkey SIVs show that they are closely related to the
human HIV (Kanki et al., 1985). The SIV which has crossed over to humans via
the polio vaccine, and is still crossing over thanks to the PEI, is
approximately 50% related to human HIV (Essex & Kanki, 1988).
According to retrovirus researchers SIV is "virtually indistinguishable from
some human variants of HIV-2" associated with West African AIDS (Curtis, 1992).
SIV has also been found in the cancer cells of an AIDS patient (Bohannon et
al., 1991). Vaccine manufacturers like Merck and Co. were so scared of these
findings that they refused to produce vaccines based on green monkey serum in
1961. Today vaccine manufacturers are shielded from law suits in a bid to make
them compliant.
The introduction and experimental trial of the OPV vaccine in Africa coincided
with the epidemic of AIDS in Africa. When this vaccine was given to the gay
population of the USA to fight recurrent genital herpes (Tager, 1974) AIDS
spread amongst the American gays (Kyle, 1992). The study of the link between
the OPV and AIDS led researchers to comment, "It is difficult to believe that
the outbreak of HIV infection in Africa at the same time and location as the
mass trial of the OPV is a coincidence". (Elswood & Stricker, 1994).
Rebutting claims of the medical community that the OPV has been "cleaned" of
these dreaded simian viruses, Tom Folkes Chief Virologist of the retrovirus
laboratory of the US CDC has said, "vaccine manufacturers could not kill one
virus and keep another virus alive". He goes on, "The fact that it's (the OPV)
a live vaccine would indicate that they had not gone through any inactivation
procedures to denature the AIDS virus, because it would probably denature the
polio virus. So the polio virus is kept alive and the SIV would just travel
with it. The theory, the possibility is real." (Curtis, 1992).
We have reasons to believe that the OPV being used in India have not been
tested for either the SV40 or SIV. Our children have thus been vaccinated for
over two decades with a potent carcinogen and also the AIDS virus by various
governments at the centre with the medical community preferring to look the
other way for reasons best known to them.
Probably a few hundred cases of polio a year (statistics before the
introduction of the OPV) is a greater threat than the massive epidemics of
Cancer, AIDS and Autism that have spread like wildfire all over the country. I
suppose all this has been done "for the greater good of mankind", and
opposition has been "taken with a pinch of salt", quoting the two phrases very
dear to the medical community.
We need not talk about the stealth viruses which have also crossed over to
humans via the OPV that are behind Chronic Fatigue Syndrome, Autism (Martin,
1995), fibromyalgia, depression and dementia in adults, and attention deficit
and behavioral disorders in children. Stealth Virus infection can also cause
severe encephalopathy (Martin, 1996).
We are sorry, we cannot allow you anymore to carry on disinformation, diseases
and death dance by furthering the depopulation "useless eaters" agenda of the
WHO and its allies. This is, therefore, absolutely the FINAL NOTICE to you to
stop your madness forthwith or we will be constrained to take a PIL either in
the Bombay High Court or in the Supreme Court.
Enough is enough, for at stake is the future of our millions of children
besides the nation's sovereignty.
"Dr.V.N. Sharma" <[EMAIL PROTECTED]> wrote: Many of you may not like
to read this long Article but just go through a few Paras to know how our
children are being treated as Experimental Animals by Money making M/cs
worldwide.
Subject: Dr P M Bhargava exposes the politics of the polio vaccine.
The politics of polio Pushpa M. Bhargava
________________________________
Even the appropriate WHO document clearly states that there is evidence that
OPV has not worked in developing countries.
________________________________
That Sabin's oral polio vaccine (OPV) has not been able to eradicate polio in
our country, is now well established (inter alia, Economic and Political
Weekly, 4-11-06, p. 4538-4540; and 23-12-06, p.5229-5237; Tehelka, 11-11-06,
p.8-9; The Hindu, Hyderabad, November 13, 2006, p.11; Down to Earth, 31-12-06,
p.24-31; Conclusions Recommendations of a National Consultative Meeting
organised by Ind ian Medical Association in New Delhi on May 14, 2006;
Editorial in the Indian Journal of Medical Research, (IJMR), January 2007, p.
1-4; and numerous other articles in some of the world's best known scientific
journals, such as Science.)
[I do not subscribe to the theory that the IPV is in any way a better choice
than the OPV. It is like comparing one monster to another; all cases of polio
in the developed countries are today attributed to the IPV advocated here which
can also cause the dreaded paralytic state "Guillain Barre Syndrome". The first
positive step should be to study the disease again with renewed intensity to
find out the real cause. And now that the OPV has been repeatedly exposed I
would like to talk again about the issue of compensation to the OPV paralysed
children who may number more than a lakh as per unofficial sources, (The
Telegraph quoted the figure of 3 lakhs in 2006). In the US recently a case of
OPV induced paralysis appeared 16 years after taking the vaccine. Is there any
such long term follow up in India? There is no other option, vaccines should
go, sense should prevail. We and our children have suffered enough of this
cruel and uncivillised, definitely
unscientific, intervention - Jagannath]
Not only that the cases of nonâpolio acute flaccid paralysis (AFP) in those
vaccinated with OPV have shown a dramatic rise. It appears that in 2005, in
Uttar Pradesh alone, 4,800 had residual paralysis, or died after acquiring
non-polio AFP, in comparison to the all-India figure of 4,793 polio cases in
1994; the 2006 data, after six doses of monovalent OPV, are worse. The
infructuous expenditure on the OPV programme would probably run into thousands
of crores.
The pity of it is that all this was anticipated (Bhargava, The Hindu, December
12, 1999 ), and that we could have easily eradicated polio from our country by
now. We did not do so because our successive governments and those who worked
for them in responsible positions such as Secretaries and Joint Secretaries in
the Ministry of Health, Directors-General of Medical and Health Services and
even of the ICMR, were primarily (exclusively?) committed to personal and
certain foreign interests and not to the cause of polio eradication. Here is
the story with which I was, in the initial stages, connected.Two types of
vaccines
There have been two types of vaccines available against polio: the injectable
Salk vaccine (IPV) and the oral Sabin vaccine (OPV) using an attenuated live
virus. Till the early 1980s, OPV was used in the developed countries to
maintain the polio-free status that had been largely achieved through the use
of IPV beginning the 1950s. By 1988, Jonas Salk (one of the most celebrated
scientists of the last century who made the first successful polio vaccine, the
IPV) had developed an enhanced potency injectable vaccine (M-IPV). In a letter
dated December 1, 1988 to me, he wrote, "It is urgent that the incidence [of
polio] be reduced as rapidly as possible. A simple way would be to administer a
single dose of the enhanced potency IPV (M-IPV), to all those of six months of
age or over who may have already received one or more doses of OPV (some of
whom we know, from experience may not have been protected), and to those of the
same age who may not have been
previously immunised against polio. A single dose of M-IPV of sufficient
potency will induce antibody and/or immunologic memory in nearly all infants of
that age. For infants less than six months of age who still possess maternal
antibody, two doses, preferably, one with DTP are necessary." I had forwarded
this letter to everyone concerned in the country with the polio vaccination
programme at that time, but no one took any note of it.Evidence against OPV
Even before I had received the above-mentioned letter from Jonas Salk, at a
meeting held in Delhi in March 1988, convened by Sam Pitroda, the then Adviser
to the Prime Minister for National Technology Missions, overwhelming evidence
was presented that OPV had not worked in India (Bhargava, The Hindu, December
12, 1999 ). Virtually every one concerned with polio was present at this
meeting at which an unambiguous decision was taken to shift to IPV.
I quote from the official minutes of this meeting:
"Expedite establishment of M-IPV programme. On moral grounds and considering
the involvement of the lives of our children, cost shall be no consideration.
Indigenous production of IPV before 1991 shall be aimed at." "Whenever children
in large numbers are dying, getting afflicted with polio, the empty and hollow
argument of their being used as guinea pigs cannot be accepted." "As new M-IPV
programme ramps up, the OPV will ramp down." Although IPV has always been more
expensive than OPV, this is compensated by the fact that one may need to take
only one or at most two doses of IPV whereas, in the case of OPV, the number of
doses could be above ten.
It was clear that, for some time, OPV will continue to be with us. In fact, the
then Secretary of the Department of Biotechnology (DBT), S. Ramachandran, had
been earlier to the Soviet Union and, with their help, a factory (BIBCOL) to
produce OPV was set up in Bulandshahr.
In keeping with the decision of the 1988 meeting â the only meeting of
experts and concerned people so far convened by the government in regard to
polio vaccination programme â another company called Indian Vaccine
Corporation Ltd (IVCOL) was set up with a capital outlay of Rs. 90 crores. Both
DBT and the Indian Petrochemicals Ltd. of Baroda had equity in it even though
the majority shares belonged to Institut Merieux, one of the world's largest,
most reliable and respected vaccine producers that was committed to produce
M-IPV which was far more heat-stable than OPV. Obliging WHO
But we hadn't reckoned with our primary commitment to the interests of the
developed countries. As already mentioned, by this time the West had decided to
replace OPV with M-IPV. Therefore, market had to be found for OPV. WHO advised
that developed countries use IPV, while developing countries use OPV. For us to
oblige WHO, two steps were necessary: (1) that BIBCOL produces no OPV of its
own; and (2) India reverses its decision to gradually shift to IPV. Both the
steps were taken. BIBCOL has not produced a single dose of OPV till today, and
the Ministry of Health decided soon after the March 1988 meeting, without any
further consultations, to shift permanently to OPV. Consequently IVCOL was
closed down after incurring substantial expenditure, and a number of senior
officers of the above Ministry got plum U.N. jobs with tax-free dollar
salaries, after retirement.
It is particularly interesting that at a conference jointly organised by the
International Comparative Virology Organisation and the WHO in New Delhi, in
January 1992, experts from all over the world indicated the preference of IPV
over OPV for any plans of eradication of polio in developing countries. Problem
continues
An interesting question that one may, therefore, ask is: if we really felt that
there was a strong scientific case for using OPV (which there wasn't), why did
we not make it ourselves. The answer is that this wouldn't have served the
foreign interests to whom we had sold ourselves, ignoring the interests of our
own people and the sane advice of our own experts based on incontrovertible
evidence. It is amusing in this context that even the appropriate WHO document
clearly states that there is evidence that OPV has not worked in developing
countries.
The 64,000-rupee question now is: would the government wake up and get out of
the clutches of WHO so that it may serve our interests and not the interest of
powers that be outside India? And if it needs endorsement from a foreign
channel, it may read the article by V.K. Bhasin in January 2008 issue of Nature
Biotechnology, Nature being perhaps the world's best-known and most respected
scientific periodical. The article says that, in 2006, there were 1,600 cases
of OPVâinduced polio plus a large number of cases of AFP from which virus was
not cultured.
So, the problem continues. But who cares! Polio is not a disease of
billionaires.(Dr. P.M.. Bhargava is former vice-chairman, National Knowledge
Commission.)
Printer friendly page
Send this article to Friends by E-Mail
"It is now 30 years since I have been confining myself to the treatment
ofchronic diseases. During those 30 years I have run against so many histories
of littlechildren who had never seen a sick day until they were vaccinated and
who, in the severalyears that have followed, have never seen a well day since.
I couldn't put my finger onthe disease they have. They just weren't strong.
Their resistance was gone. They wereperfectly well before they were vaccinated.
They have never been well since. "---Dr. William Howard Hay
Jharkhand Network | Jharkhand.org.in/network
